Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Radiation Oncology (London, England)|August 29, 2020
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual diseaseYa Zeng, Jianjiao Ni, Fan Yu, et al.Clinical & Experimental Metastasis|May 29, 2025
Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectinibXi Yang, Xiao Chu, Ruiting Ye, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 18, 2024
Enhancing the prediction of symptomatic radiation pneumonitis for locally advanced non-small-cell lung cancer by combining 3D deep learning-derived imaging features with dose-volume metrics: a two-center studyYan Kong, Mingming Su, Yan Zhu, et al.Annals of Surgical Oncology|June 13, 2019
Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node RatioYida Li, Weixin Zhao, Jianjiao Ni, et al.Journal of Cancer|November 29, 2019
Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment ModalitiesLi Chu, Jianjiao Ni, Xi Yang, et al.Cancer Immunology, Immunotherapy : CII|June 4, 2024
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinomaYue Zhou, Li Chu, Shuyan Li, et al.Cancer Immunology, Immunotherapy : CII|March 19, 2025
Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational studyJie Gao, Aihua Lan, Xi Yang, et al.International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation TherapyTiantian Guo, Jianjiao Ni, Xi Yang, et al.Plos Medicine|August 1, 2025
Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from ChinaHongru Chen, Lu Yu, Fei Liang, et al.The British Journal of Radiology|May 25, 2022
Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisonsDayu Xu, Fan Yu, Tiantian Guo, et al.Pageof 8